Vertebroplasty and Kyphoplasty Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The vertebroplasty & kyphoplasty market size has grown strongly in recent years. It will grow from $0.97 billion in 2024 to $1.04 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to aging population and osteoporosis prevalence, advancements in minimally invasive techniques, rising awareness and diagnosis, increasing lifestyle-related factors, growing burden on healthcare systems.

The vertebroplasty & kyphoplasty market size is expected to see strong growth in the next few years. It will grow to $1.28 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to expansion of geriatric care services, development of biocompatible bone cement, increased adoption of outpatient procedures, focus on value-based healthcare, growing geriatric population. Major trends in the forecast period include research and development in spinal interventions, expansion of ambulatory surgical centers, technological innovations in bone cement, technological advancements in procedures, healthcare cost containment and reimbursement challenges.

The increasing incidence of spinal injuries resulting from sports-related activities is expected to drive the growth of the vertebroplasty and kyphoplasty markets. Sports-related spinal injuries involve damage to the spine caused by participating in physical activities. The rise in such injuries includes conditions like vertebral compression fractures, spondylolisthesis, and herniated discs, which often require minimally invasive treatments such as vertebroplasty and kyphoplasty. These procedures involve injecting bone cement into damaged vertebrae. For example, in November 2023, the New Zealand Spinal Trust, a disability services organization, reported that the incidence rate in New Zealand reached 45 per million in 2022, up from 41 per million in 2021, which is comparable to the 44 per million recorded in 2020, according to 2022 NZSCIR data. In 2022, males accounted for 74% of those with traumatic spinal cord injuries (tSCI), while females made up 33% of those with non-traumatic spinal cord injuries (NTSCI). As a result, the growing prevalence of sports-related spinal injuries is anticipated to fuel the expansion of the vertebroplasty and kyphoplasty markets.

The growth of the vertebroplasty and kyphoplasty market is expected to be fueled by the increasing geriatric population. As individuals aged 65 and older often require specialized care due to age-related health needs, vertebroplasty and kyphoplasty procedures play a crucial role in providing minimally invasive solutions for alleviating pain and stabilizing vertebral compression fractures in the elderly. The World Health Organization projected that one-sixth of the global population would be 60 or older by 2030, reaching an estimated 2.1 billion elderly individuals by 2050. Therefore, the growing geriatric population is identified as a key driver for the expansion of the vertebroplasty and kyphoplasty market.

Leading companies in the vertebroplasty and kyphoplasty market are forming strategic partnerships to develop the unipedicular balloon catheter for treating vertebral compression fractures. Strategic partnerships involve companies leveraging their combined strengths and resources to achieve shared success. For example, in June 2024, Medtronic Plc, an Ireland-based medical technology firm, entered into a partnership with Merit Medical Systems Inc., a US-based medical device company. Through this collaboration, they aim to develop a unipedicular, steerable balloon catheter for treating vertebral compression fractures (VCF) in the United States. This partnership builds on the existing relationship between Medtronic and Merit, with Merit already supplying Medtronic's Kyphon Xpander Inflation Syringes for balloon kyphoplasty procedures. The Kyphon KyphoFlex is designed to enable controlled, precise, and targeted cavity creation during vertebral augmentation. This new unipedicular solution will complement Medtronic’s current bipedicular balloon kyphoplasty offering, providing clinicians with greater flexibility and additional treatment options.

In October 2022, Halma PLC, a UK-based company focusing on safety, health, and environmental technologies, acquired IZI Medical Products LLC for $172.13 million. This strategic acquisition is aimed at strengthening Halma plc's portfolio in the healthcare sector, particularly in minimally invasive diagnosis and treatment, leveraging IZI Medical Products' expertise in vertebral compression fractures and related spinal issues, including vertebroplasty and kyphoplasty procedures.

Major companies operating in the vertebroplasty and kyphoplasty market report are Cardinal Health, Johnson and Johnson (DePuy Synthes), Medtronic Plc., Stryker Corporation, GS Solutions Inc., Lepu Medical Technology (Beijing)Co.Ltd., Merit Medical Systems Inc., Globus Medical Inc., Alphatec Spine Inc., Rontis Corporation, Spectrum Plastics Group., SOMATEX Medical Technologies GmbH, Zavation LLC, MJ Surgical, Benvenue Medical, Joimax GmbH, Laurane Medical LLC, Spine Wave Inc., G21 S.r.l., BM Korea Co. Ltd., Biopsybell Medical, Teknimed, Joline GmbH And Co. KG, SCW Medicath Ltd., Stöckli Medical AG, Jiangsu ChangMei Medtech Co.Ltd., IZI Medical Products.

North America was the largest region in the vertebroplasty and kyphoplasty market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vertebroplasty and kyphoplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vertebroplasty and kyphoplasty market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vertebroplasty and kyphoplasty market consists of revenues earned by entities through services such as diagnostic evaluation services, consultations, post-operative care, and monitoring services to assist individuals with vertebral compression fractures and related conditions. The vertebroplasty and kyphoplasty market also includes sales of medical imaging equipment, pain management devices, and patient monitoring equipment that help in diagnosis, pain relief, and comprehensive patient care during and after procedures. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Vertebroplasty and kyphoplasty are both minimally invasive surgical interventions employed to address non-healing vertebral compression fractures (VCFs) in the spine. These procedures entail the injection of polymethyl methacrylate (PMMA) into the vertebral body to reinforce its structure.

The primary products associated with vertebroplasty and kyphoplasty include kyphoplasty devices and vertebroplasty devices. Kyphoplasty devices are specialized medical tools designed for utilization in kyphoplasty procedures, applied in both vertebroplastic and kyphoplastic surgeries performed by hospitals and ambulatory surgical centers.

The vertebroplasty and kyphoplasty market research report is one of a series of new reports that provides vertebroplasty and kyphoplasty market statistics, including the vertebroplasty and kyphoplasty industry global market size, regional shares, competitors with vertebroplasty and kyphoplasty market share, detailed vertebroplasty and kyphoplasty market segments, market trends and opportunities, and any further data you may need to thrive in the vertebroplasty and kyphoplasty industry. This vertebroplasty and kyphoplasty market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.